Lacosamide is indicated for the treatment of partial-onset seizures (monotherapy or adjunctive therapy) and as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
